NM_006701.5:c.88_110delTTCGGCCACGACTGGGATCCTAC
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_006701.5(TXNL4A):c.88_110delTTCGGCCACGACTGGGATCCTAC(p.Phe30ValfsTer16) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000689 in 1,451,470 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_006701.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.89e-7 AC: 1AN: 1451470Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 722018
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome Pathogenic:2
The p.Phe30ValfsX16 variant in TXNL4A has not been previously reported in individuals with TXNL4A-related craniofacial disorders, including Burn-McKeown syndrome (BMKS), but has been reported by other clinical laboratories in ClinVar (Variation ID 451615). It was absent from large population studies (gnomAD v.3.1.2). This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 30 and leads to a premature termination codon 16 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Biallelic loss of function of the TXNL4A gene is strongly associated with TXNL4A-related craniofacial disorders, including BMKS (Wieczorek 2014 PMID: 25434003, Wood 2020 PMID: 32735620). The majority of individuals reported with this condition have been found to have a loss of function variant on one allele and a 34-bp promoter deletion on the other (Wieczorek 2014 PMID: 25434003). In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive TXNL4A-related craniofacial disorders. ACMG/AMP Criteria applied: PVS1, PM2_Supporting. -
- -
not provided Pathogenic:1
The c.88_110del23 variant in the TXNL4A gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.88_110del23 variant causes a frameshift starting with codon Phenylalanine 30, changes this amino acid to a Valine residue, and creates a premature Stop codon at position 16 of the new reading frame, denoted p.Phe30ValfsX16. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.88_110del23 variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.88_110del23 as a likely pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at